Literature DB >> 953984

Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.

H Farkas-Himsley, R Cheung.   

Abstract

Several bacteriocins, bacterial proteinaceous antibiotics, are shown to markedly inhibit the division of various established (neoplastic) mammalian cell lines. The bacteriocins tested originated from Escherichia coli, Pseudomonas aeruginosa, Vibrio cholerae, and Vibrio eltor. Using exponentially growing L60T mouse fibroblasts, the inhibitory effect was concentration dependent, and a growth inhibitory unit, equivalent to cytotoxic index 50, was established. Expression of toxicity as a function of duration of exposure to pyocin required 3 to 4 hr. DNA synthesis was inhibited and reflected the effects on growth inhibition. Maximal sensitivity to the bacteriocin was observed prior to mitosis in the G2 phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 953984

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts.

Authors:  H Müller; C Kettelhack; M Kettelhack; H G Sonntag; G Keilich; R Brossmer; J Richards; V Kinzel; E Bäuerlein; H Pech
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Characterization, Toxicity, and Optimization for the Growth and Production of Bacteriocin-like Substances by Lactobacillus curvatus.

Authors:  Graciele Daiana Funck; Juliana de Lima Marques; Guilherme da Silva Dannenberg; Claudio Eduardo Dos Santos Cruxen; Carla Pohl Sehn; Marina Prigol; Márcia Rósula Poetini Silva; Wladimir Padilha da Silva; Ângela Maria Fiorentini
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

3.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 4.  Vibrio spp. and Their Vibriocin as a Vibriosis Control Measure in Aquaculture.

Authors:  Hassan Sheikh; Akbar John; Najiah Musa; Laith A Abdulrazzak; Mulham Alfatama; Anis Fadhlina
Journal:  Appl Biochem Biotechnol       Date:  2022-04-22       Impact factor: 3.094

5.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

6.  The cytotoxic and cytocidal effect of colicin E3 on mammalian tissue cells.

Authors:  J Smarda; V Obdrzálek; I Táborský; J Mach
Journal:  Folia Microbiol (Praha)       Date:  1978       Impact factor: 2.099

7.  The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.

Authors:  H Farkas-Himsley; R Hill; B Rosen; S Arab; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  Human tumor cells are selectively inhibited by colicins.

Authors:  J Chumchalová; J Smarda
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.629

Review 9.  Bacteriocins as Potential Anticancer Agents.

Authors:  Sumanpreet Kaur; Sukhraj Kaur
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

10.  Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.

Authors:  Baljinder Kaur; Praveen P Balgir; Bharti Mittu; Balvir Kumar; Neena Garg
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.